original articles Annals of Oncology 23: 3040–3045, 2012 doi:[removed]annonc mds473 Published online 19 October 2012 - Regional Cancer Centre, Thiruvananthapuram - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2013-04-15 14:28:39 Oncology Breast cancer Prostate cancer Health equity National Comprehensive Cancer Network Personalized medicine Cancer research Management of cancer Regional Cancer Centre Thiruvananthapuram Medicine Health Cancer organizations		original articles Annals of Oncology 23: 3040–3045, 2012 doi:[removed]annonc/mds473 Published online 19 October 2012 Add to Reading List Source URL: ibcrf.org Download Document from Source Website File Size: 96,29 KB Share Document on Facebook

	Journal of Machine Learning ResearchSubmitted 8/15; Revised 3/16; PublishedStructure-Leveraged Methods in Breast Cancer Risk Prediction DocID: 1vq0d - View Document
	Multicausality: Confounding - Assignment solutions 1. a. Reserpine is a risk factor. Overall, the incidence of breast cancer isper 100,000 women-years in reserpine users and 6.14 per 100,000 women-years in nonuser DocID: 1vpNA - View Document
	Frequently Asked Questions: Trainees seeking a PhD education in Cancer Biology or a related area with a focus on Breast Cancer Health Disparities. 1. What is the Komen Graduate Training in Disparities Research Grant (GT DocID: 1voV1 - View Document
	_____________________________________________________________ What to Do When Someone You Know Has Been Diagnosed with Breast Cancer [Last revised Mar 2014] DocID: 1vlqg - View Document
	Tangeretin inhibits the proliferation of human breast cancer cells via CYP1A1/CYP1B1 enzyme induction and CYP1A1/CYP1B1–mediated metabolism to the product 4′ hydroxy tangeretin DocID: 1vl9e - View Document